Evidence map›Paper›PMID 39624253›Full record

ArticleIJID regions2024

Profile of bacterial resistance in emergency wards, non-intensive care unit areas, and intensive care units in Mexican hospitals with the antimicrobial stewardship program.

Elvira Garza-González, Marcela Elizabeth Nunez-Martinez, Porfirio Zuñiga-Mejia, Dolores Márquez-Monzón, María Del Rayo Morfín-Otero, Eduardo Rodríguez-Noriega, Paulo Castañeda-Méndez, Jose Manuel Ramírez-Rodríguez, Alba Guadalupe Juárez-Lomelí, Luis Javier Quintanilla-Cazarez and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Elvira Garza-GonzálezFacultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Marcela Elizabeth Nunez-MartinezCentro Médico ABC, Observatorio, Mexico City, Mexico.
Porfirio Zuñiga-MejiaCentro Médico ABC, Observatorio, Mexico City, Mexico.
Dolores Márquez-MonzónHospital Angeles Metropolitano, Mexico City, Mexico.
María Del Rayo Morfín-OteroHospital Civil Viejo de Guadalajara, Guadalajara, Mexico.
Eduardo Rodríguez-NoriegaHospital Civil Viejo de Guadalajara, Guadalajara, Mexico.
Paulo Castañeda-MéndezHospital Medica Sur, Mexico City, Mexico.
Jose Manuel Ramírez-RodríguezHospital San Javier, Guadalajara, Mexico.
Alba Guadalupe Juárez-LomelíHospital San Javier, Guadalajara, Mexico.
Luis Javier Quintanilla-CazarezHospital Angeles Valle Oriente, Monterrey, Mexico.
Inés Saldivar-CornejoHospital Oncología Centro Médico XXI, Mexico City, Mexico.
Michel Martínez-ResendezHospital San José Tecnológico de Monterrey, Monterrey, Mexico.
Carlos Vallejo UgaldeHospital San José, Queretaro, Mexico.
Miriam Lugo-TaveraClínica De Merida, Merida, Mexico.
Elida González AguilarHospital Aranda de la Parra Leon, Guanajuato, Mexico.
Juan José Morales-ReyesHospital Civil Nuevo de Guadalajara, Guadalajara, Mexico.
Itzel Guadalupe Meza SánchezHospital General Miguel Silva, Morelia, Mexico.
Guillermo Damian Ortega MoralesHospital General Miguel Silva, Morelia, Mexico.
Norberta Vianay Navarro-VargasHospital Lazaro Cardenas ISSSTE, Chihuahua, Mexico.
Jose Luis VallejoMSD, Mexico City, México.
Carlos Peréz Bolde-VillarrealMSD, Mexico City, México.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Bacterial infections are important causes of death. Some reports have shown that the COVID-19 pandemic may have had an impact on drug resistance. The objective of this work was to compare the resistance profiles between 2019 and 2020 in the emergency department, non-intensive care units (ICU), and ICU areas in Mexican hospitals. Methods: Databases from 15 hospitals from eight states in Mexico including susceptibility results for Results: A statistically significant decrease in resistance to imipenem was observed for Conclusions: A decrease in carbapenem resistance for

Indexed as

AntibioticsAntimicrobial resistanceMDRXDR y PDR

Identifiers

PMID39624253
PMCPMC11609382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.